Supplementary Table S1 from Validation of the Prognostic Performance of Breast Cancer Index in Hormone Receptor–Positive Postmenopausal Breast Cancer Patients in the TEAM Trial

crossref(2024)

引用 0|浏览1
暂无评分
摘要

Supplemental Table 1. Prognostic performance of BCI and BCIN+ optimized cut-points for late DR in all patients with N0 and N1 breast cancers, as well as in HER2- subsets, respectively.

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要